|
Outi Varpuluoma, Laura Huilaja, Kaisa Tasanen, Reply to: “Comment on ‘Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study’”, Journal of the American Academy of Dermatology, Volume 79, Issue 6, 2018, Pages e113-e114, ISSN 0190-9622, https://doi.org/10.1016/j.jaad.2018.06.042
Reply to : "comment on 'oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: a Finnish nationwide case control study'"
Saved in:
|
Author: |
Varpuluoma, Outi1; Huilaja, Laura1; Tasanen, Kaisa1 |
Organizations: |
1PEDEGO Research Unit, University of Oulu, Department of Dermatology and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland |
Format: |
article
|
Version: |
accepted version |
Access: |
open |
Online Access: |
PDF Full Text (PDF,
0.1 MB)
|
Persistent link: |
http://urn.fi/urn:nbn:fi-fe2019102835041
|
Language: |
English
|
Published: |
Elsevier,
2018
|
Publish Date: |
2019-11-09
|
Series: |
Journal of the American Academy of Dermatology
|
ISSN: |
0190-9622 |
ISSN-E: |
1097-6787 |
ISSN-L: |
0190-9622 |
Volume: |
79 |
Issue: |
6 |
Pages: |
E113 - E114 |
DOI: |
10.1016/j.jaad.2018.06.042 |
OADOI: |
https://oadoi.org/10.1016/j.jaad.2018.06.042 |
Type of Publication: |
B1 Journal article
|
Field of Science: |
3121 General medicine, internal medicine and other clinical medicine
|
Subjects: |
|
Copyright information: |
© 2018 by the American Academy of Dermatology, Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/.
|
|
https://creativecommons.org/licenses/by-nc-nd/4.0/
|